🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

U.S. CDC says all adults should get COVID-19 booster shots

Published 11/29/2021, 04:52 PM
Updated 11/29/2021, 08:38 PM
© Reuters. FILE PHOTO: Nurses converses with a patients as they check in before they receive their coronavirus disease (COVID-19) booster vaccination during a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, U.S., September 29, 2021.  REUTERS/Emily Elconi
PFE
-
JNJ
-
MRNA
-

(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) said on Monday everyone aged 18 years and older should get a booster shot, as it looks to tackle a new and highly infectious strain of the coronavirus that is quickly spreading across the globe.

The update comes after President Joe Biden on Monday called for wider vaccination to curb the spread of the Omicron coronavirus variant, which was first detected in southern Africa.

The U.S. health regulators last week expanded the eligibility for booster shots of COVID-19 vaccines to all adults aged 18 and older either six months after their initial Pfizer (NYSE:PFE) or Moderna (NASDAQ:MRNA) vaccine doses or two months after their Johnson & Johnson (NYSE:JNJ) shot.

The CDC had, however, stopped short of saying all adults aged 18 to 49 should get the additional shots.

The agency is taking a more cautious stance as Omicron's emergence further emphasizes the importance of vaccination and boosters, CDC Director Rochelle Walensky said in a statement on Monday.

Amid the renewed emphasis, Pfizer and partner BioNTech are expected to ask the U.S. Food and Drug Administration (FDA) in the coming days to authorize their booster shots for those aged 16 and 17 years, the Washington Post reported on Monday, citing sources.

Separately, the Wall Street Journal reported that the FDA could approve booster doses for 16 and 17 year-olds as soon as next week.

Pfizer, BioNTech and the FDA did not respond to Reuters' requests for comment.

Omicron, which the World Health Organization said carried a very high risk for fueling infection surges, has now been confirmed in several countries including Germany, Hong Kong, South Africa and Canada.

© Reuters. FILE PHOTO: Nurses converses with a patients as they check in before they receive their coronavirus disease (COVID-19) booster vaccination during a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, U.S., September 29, 2021.  REUTERS/Emily Elconin

Scientists in the United States and around the world are urgently examining vaccine effectiveness related to this variant, the CDC said.

The agency also said the 47 million adults who are not yet vaccinated are encouraged to get vaccinated as soon as possible.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.